| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5266309
Max Phase: Preclinical
Molecular Formula: C13H8N4S2
Molecular Weight: 284.37
Associated Items:
Representations
Canonical SMILES: N#Cc1ccc(Nc2nc(-c3nccs3)cs2)cc1
Standard InChI: InChI=1S/C13H8N4S2/c14-7-9-1-3-10(4-2-9)16-13-17-11(8-19-13)12-15-5-6-18-12/h1-6,8H,(H,16,17)
Standard InChI Key: LJLQLQMMOAIZPC-UHFFFAOYSA-N
Associated Targets(Human)
Cytochrome P450 1B1 1148 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 284.37 | Molecular Weight (Monoisotopic): 284.0190 | AlogP: 3.88 | #Rotatable Bonds: 3 |
| Polar Surface Area: 61.60 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.02 | CX Basic pKa: 1.75 | CX LogP: 3.68 | CX LogD: 3.68 |
| Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.79 | Np Likeness Score: -2.52 |
References
| 1. Mao J, Wang D, Xu P, Wang Y, Zhang H, Wang S, Xu F, Wang J, Zhang F.. (2022) Structure-Based Drug Design and Synthesis of Novel N-Aryl-2,4-bithiazole-2-amine CYP1B1-Selective Inhibitors in Overcoming Taxol Resistance in A549 Cells., 65 (24.0): [PMID:36512763] [10.1021/acs.jmedchem.2c01306] |
Source
Source(1):